UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Clinical characteristics and outcomes of pregnant women with COVID-19 and the risk of vertical transmission: a systematic review

Archives of gynecology and obstetrics, 2021-02, Vol.303 (2), p.337-345

2021

Volltextzugriff (PDF)

Prevalence and risk factors of thrombotic events on patients with COVID-19: a systematic review and meta-analysis

Thrombosis journal, 2021-05, Vol.19 (1), p.32-32, Article 32

2021

Volltextzugriff (PDF)

The biodiversity Composition of Microbiome in Ovarian Carcinoma Patients

Scientific reports, 2019-02, Vol.9 (1), p.1691-1691, Article 1691

2019

Volltextzugriff (PDF)

Genome-wide profiling of HPV integration in cervical cancer identifies clustered genomic hot spots and a potential microhomology-mediated integration mechanism

Nature genetics, 2015-02, Vol.47 (2), p.158-163

2015

Volltextzugriff (PDF)

Heterogeneity of immune microenvironment in ovarian cancer and its clinical significance: a retrospective study

Oncoimmunology, 2020-01, Vol.9 (1), p.1760067-1760067

2020

Volltextzugriff (PDF)

Integrated analysis reveals the participation of IL4I1, ITGB7, and FUT7 in reshaping the TNBC immune microenvironment by targeting glycolysis

Annals of medicine (Helsinki), 2021-01, Vol.53 (1), p.916-928

2021

Volltextzugriff (PDF)

Editorial: Towards better and personalized management of ovarian cancer in China

BJOG : an international journal of obstetrics and gynaecology, 2022-11, Vol.129 (S2), p.3-4

Gao, Qinglei

2022

Volltextzugriff (PDF)

The role of Sema4D/CD100 as a therapeutic target for tumor microenvironments and for autoimmune, neuroimmune and bone diseases

Expert opinion on therapeutic targets, 2016-07, Vol.20 (7), p.885-901

2016

Volltextzugriff (PDF)

RAD54B potentiates tumor growth and predicts poor prognosis of patients with luminal A breast cancer

Biomedicine & pharmacotherapy, 2019-10, Vol.118, p.109341-109341, Article 109341

2019

Volltextzugriff (PDF)

TALEN-mediated targeting of HPV oncogenes ameliorates HPV-related cervical malignancy

The Journal of clinical investigation, 2015-01, Vol.125 (1), p.425-436

2015

Volltextzugriff (PDF)

Dose-dense regimen versus conventional three-weekly paclitaxel combination with carboplatin chemotherapy in first-line ovarian cancer treatment: a systematic review and meta-analysis

Journal of ovarian research, 2023-07, Vol.16 (1), p.136-136, Article 136

2023

Volltextzugriff (PDF)

Signaling pathways in macrophages: molecular mechanisms and therapeutic targets

MedComm (2020), 2023-10, Vol.4 (5), p.e349-e349

2023

Volltextzugriff (PDF)

Risk stratification of cervical lesions using capture sequencing and machine learning method based on HPV and human integrated genomic profiles

Carcinogenesis (New York), 2019-10, Vol.40 (10), p.1220-1228

2019

Volltextzugriff (PDF)

Silencing of the STAT3 signaling pathway reverses the inherent and induced chemoresistance of human ovarian cancer cells

Biochemical and biophysical research communications, 2013-05, Vol.435 (2), p.188-194

2013

Volltextzugriff (PDF)

Expression of PAWR predicts prognosis of ovarian cancer

Cancer cell international, 2020-12, Vol.20 (1), p.598-598, Article 598

2020

Volltextzugriff (PDF)

HPV-CCDC106 integration alters local chromosome architecture and hijacks an enhancer by three-dimensional genome structure remodeling in cervical cancer

Journal of genetics and genomics, 2020-08, Vol.47 (8), p.437-450

2020

Volltextzugriff (PDF)

Immunological alternation in COVID-19 patients with cancer and its implications on mortality

Oncoimmunology, 2021-01, Vol.10 (1), p.1854424

2021

Volltextzugriff (PDF)

Risk factors for developing into critical COVID-19 patients in Wuhan, China: A multicenter, retrospective, cohort study

EClinicalMedicine, 2020-08, Vol.25, p.100471-100471, Article 100471

2020

Volltextzugriff (PDF)

Effectiveness and Safety of Niraparib as Neoadjuvant Therapy in Advanced Ovarian Cancer With Homologous Recombination Deficiency (NANT): Study Protocol for a Prospective, Multicenter, Exploratory, Phase 2, Single-Arm Study

Frontiers in oncology, 2022-03, Vol.12, p.852772-852772

2022

Volltextzugriff (PDF)

Cyclin-Dependent Kinase Inhibitors Function as Potential Immune Regulators via Inducing Pyroptosis in Triple Negative Breast Cancer

Frontiers in oncology, 2022-06, Vol.12, p.820696-820696

2022

Volltextzugriff (PDF)

Development and validation of an online model to predict critical COVID-19 with immune-inflammatory parameters

Journal of intensive care, 2021-02, Vol.9 (1), p.19-12, Article 19

2021

Volltextzugriff (PDF)

Decreased DHRS2 expression is associated with HDACi resistance and poor prognosis in ovarian cancer

Epigenetics, 2020-02, Vol.15 (1-2), p.122-133

2020

Volltextzugriff (PDF)

PARP inhibitors promote stromal fibroblast activation by enhancing CCL5 autocrine signaling in ovarian cancer

NPJ precision oncology, 2021-06, Vol.5 (1), p.49-49, Article 49

2021

Volltextzugriff (PDF)

Dicer reprograms stromal fibroblasts to a pro-inflammatory and tumor-promoting phenotype in ovarian cancer

Cancer letters, 2018-02, Vol.415, p.20-29

2018

Volltextzugriff (PDF)

Correction to: The physical state of HPV16 infection and its clinical significance in cancer precursor lesion and cervical carcinoma

Journal of cancer research and clinical oncology, 2020-05, Vol.146 (5), p.1377-1377

2020

Volltextzugriff (PDF)

1 – 25 von 259

Suche als RSS-Feed

Aktive Filter

ThemaMice

ThemaTumors

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(218)
Mit Volltextzugriff
(218)

Publikationsform

Sprache

Englisch
(252)
Chinesisch
(8)

Erscheinungsjahr

n.n

Thema

Science & Technology
(150)
Life Sciences & Biomedicine
(97)
Humans
(63)
Female
(52)
Oncology
(40)
Technology
(40)
Ovarian Cancer
(33)
Animals
(29)
Physical Sciences
(27)
Apoptosis
(19)
Materials Science
(18)
Medicine, Research & Experimental
(18)
Middle Aged
(18)
Research & Experimental Medicine
(18)
Materials Science, Multidisciplinary
(17)
Ovarian Neoplasms - Drug Therapy
(17)
Prognosis
(17)
Chemistry
(16)
Adult
(15)
Cell Line, Tumor
(15)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

Clinical characteristics and outcomes of pregnant women with COVID-19 and the risk of vertical transmission: a systematic review

Prevalence and risk factors of thrombotic events on patients with COVID-19: a systematic review and meta-analysis

The biodiversity Composition of Microbiome in Ovarian Carcinoma Patients

Genome-wide profiling of HPV integration in cervical cancer identifies clustered genomic hot spots and a potential microhomology-mediated integration mechanism

Heterogeneity of immune microenvironment in ovarian cancer and its clinical significance: a retrospective study

Integrated analysis reveals the participation of IL4I1, ITGB7, and FUT7 in reshaping the TNBC immune microenvironment by targeting glycolysis

Editorial: Towards better and personalized management of ovarian cancer in China

The role of Sema4D/CD100 as a therapeutic target for tumor microenvironments and for autoimmune, neuroimmune and bone diseases

RAD54B potentiates tumor growth and predicts poor prognosis of patients with luminal A breast cancer

TALEN-mediated targeting of HPV oncogenes ameliorates HPV-related cervical malignancy

Dose-dense regimen versus conventional three-weekly paclitaxel combination with carboplatin chemotherapy in first-line ovarian cancer treatment: a systematic review and meta-analysis

Signaling pathways in macrophages: molecular mechanisms and therapeutic targets

Risk stratification of cervical lesions using capture sequencing and machine learning method based on HPV and human integrated genomic profiles

Silencing of the STAT3 signaling pathway reverses the inherent and induced chemoresistance of human ovarian cancer cells

Expression of PAWR predicts prognosis of ovarian cancer

HPV-CCDC106 integration alters local chromosome architecture and hijacks an enhancer by three-dimensional genome structure remodeling in cervical cancer

Immunological alternation in COVID-19 patients with cancer and its implications on mortality

Risk factors for developing into critical COVID-19 patients in Wuhan, China: A multicenter, retrospective, cohort study

Effectiveness and Safety of Niraparib as Neoadjuvant Therapy in Advanced Ovarian Cancer With Homologous Recombination Deficiency (NANT): Study Protocol for a Prospective, Multicenter, Exploratory, Phase 2, Single-Arm Study

Cyclin-Dependent Kinase Inhibitors Function as Potential Immune Regulators via Inducing Pyroptosis in Triple Negative Breast Cancer

Development and validation of an online model to predict critical COVID-19 with immune-inflammatory parameters

Decreased DHRS2 expression is associated with HDACi resistance and poor prognosis in ovarian cancer

PARP inhibitors promote stromal fibroblast activation by enhancing CCL5 autocrine signaling in ovarian cancer

Dicer reprograms stromal fibroblasts to a pro-inflammatory and tumor-promoting phenotype in ovarian cancer

Correction to: The physical state of HPV16 infection and its clinical significance in cancer precursor lesion and cervical carcinoma

Aktive Filter

Suchergebnisse filtern